Ceftriaxone-induced Hemolytic Anemia: Case Report and Review of Literature

被引：18

作者：

Northrop, Michael S. ^{[1
]}

Agarwal, Hemant S. ^{[1
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2015年 / 37卷 / 01期

关键词：

ceftriaxone; immune hemolytic anemia; acute renal failure; multiple organ failure; drug induced; SICKLE-CELL-DISEASE; IMMUNODEFICIENCY-VIRUS-INFECTION; ACUTE-RENAL-FAILURE; FATAL HEMOLYSIS; PEDIATRIC-PATIENTS; IMMUNE HEMOLYSIS; CHILD; ANTIBODIES; ISCHEMIA; THERAPY;

D O I：

10.1097/MPH.0000000000000181

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ceftriaxone is a frequently used empiric antibiotic in children. Acute hemolysis is a rare side effect of ceftriaxone therapy associated with a high mortality rate. A 14-year-old boy suffering from Crohn disease developed bacterial pneumonia that was treated with ceftriaxone. We report successful management of ceftriaxone-induced hemolytic anemia (CIHA) in this patient and review the CIHA literature in pediatric patients. Early recognition of CIHA with prompt discontinuation of ceftriaxone therapy may have a beneficial role in reduction of high mortality seen in these patients.

引用

页码：E63 / E66

页数：4

共 33 条

[1] Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests [J].

Arndt, PA ;

Leger, RM ;

Garratty, G .

TRANSFUSION, 1999, 39 (11-12) :1239-1246

[2] Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia (CME) [J].

Arndt, Patricia A. ;

Leger, Regina M. ;

Garratty, George .

TRANSFUSION, 2012, 52 (03) :602-612

[3]

Bell Michael J, 2005, Pediatr Crit Care Med, V6, P363, DOI 10.1097/01.PCC.0000161285.12396.FF

[4] FATAL HEMOLYSIS INDUCED BY CEFTRIAXONE IN A CHILD WITH SICKLE-CELL-ANEMIA [J].

BERNINI, JC ;

MUSTAFA, MM ;

SUTOR, LJ ;

BUCHANAN, GR .

JOURNAL OF PEDIATRICS, 1995, 126 (05) :813-815

[5] Ceftriaxone-Induced Hemolysis in a Child With Lyme Arthritis: A Case for Antimicrobial Stewardship [J].

Boggs, Sarah R. ;

Cunnion, Kenji M. ;

Raafat, Reem H. .

PEDIATRICS, 2011, 128 (05) :E1289-E1292

[6] Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome [J].

BorgnaPignatti, C ;

Bezzi, TM ;

Reverberi, R .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (12) :1116-1117

[7] Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance [J].

Castellino, SM ;

Combs, MR ;

Zimmerman, SA ;

Issitt, PD ;

Ware, RE .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) :189-194

[8] Ceftriaxone-induced haemolytic anaemia in a child with no immune deficiency or haematological disease [J].

Çitak, A ;

Garratty, G ;

Ücsel, R ;

Karabocuoglu, M ;

Uzel, N .

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2002, 38 (02) :209-210

[9] Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration [J].

Corso, M ;

Ravindranath, TM .

PEDIATRIC EMERGENCY CARE, 2005, 21 (02) :99-101

[10] Ceftriaxone-related hemolysis and acute renal failure [J].

Demirkaya, E ;

Atay, AA ;

Musabak, U ;

Sengul, A ;

Gok, F .

PEDIATRIC NEPHROLOGY, 2006, 21 (05) :733-736

← 1 2 3 4 →